CHE

As of 2026-09-10, CHE scores 53out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. CHE trades at $514.40, within its fair-value band.

CHE scores 53 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 53. Its strongest factor is value at 75 (strong), where it screens cheap on the model's valuation inputs, followed by momentum at 54. The weakest is volume at 45, where volume gives little confirmation. Among Healthcare stocks it ranks in roughly the top 25% of the Healthcare names the model scores.

On valuation, CHE is priced in the upper part of its recent range. The blended composite before the macro overlay was 55. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on CHE, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where CHE sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for CHE runs $419.69–$546.17. Current price $514.40 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.